Our study showed for the first time that IL-23p19 and IL-17RA signaling were necessary to trigger late pulmonary inflammation and fibrosis and confirmed by IL-17A neutralization that IL-17A is required for late disease [11]. This evidence concerns the gene IL23A and inflammatory response.